Home/Recalls/CPSC-16232
CPSCGeneral Alert

Novel Laboratories Recalls Zolpidem Tartrate Blister Packs Due to Failure to Meet Child-Resistant Closure Requirement; Risk of Poisoning

Published: July 27, 2016Recall ID: 16232Category: generalCountry: US

Reason for Recall / Hazard

The packaging for the prescription drug is not child-resistant as required by the Poison Prevention Packaging Act, posing a risk of poisoning if swallowed by children.

Product Description & Identification

This recall involves 1.75 mg and 3.5 mg Zolpidem Tartrate sublingual (rapid dissolve) tablets from Novel Laboratories. The prescription medication is a sleep drug. The packaging for the 1.75 mg tablets has lot number M16140A, 1.75 mg and national drug code (NDC) 43386-762-30. The packaging for the 3.5 mg tablets has lot number M16144A, 3.5mg and national drug code (NDC) 43386-761-30. The Zolpidem Tartrate is packaged as a single tablet in a peel-and-push blister pack inside an outer open-ended pouch with 30 pouches per box. The lot number and an expiration date of 02/2018 are printed on the bottom left of the pouches. The NDC is printed on the top left corner of the boxes. "Gavis" is printed in blue on the center of the white boxes and pouches.

Affected Products

Zolpidem Tartrate Sublingual tablets

Additional Source Details

FieldValue
U R Lhttps://www.cpsc.gov/Recalls/2016/Novel-Laboratories-Recalls-Zolpidem-Tartrate-Blister-Packs
TitleNovel Laboratories Recalls Zolpidem Tartrate Blister Packs Due to Failure to Meet Child-Resistant Closure Requirement; Risk of Poisoning
Images › 1 › U R Lhttps://www.cpsc.gov/s3fs-public/Recall.2016.16232.16232a.jpg
Images › 1 › CaptionNovel Laboratories sleep tablets 1.75 mg box (front)
Images › 2 › U R Lhttps://www.cpsc.gov/s3fs-public/Recall.2016.16232.16232b.jpg
Images › 2 › CaptionNovel Laboratories sleep tablets 1.75 mg envelope (front)
Images › 3 › U R Lhttps://www.cpsc.gov/s3fs-public/Recall.2016.16232.16232c.jpg
Images › 3 › CaptionNovel Laboratories sleep tablets 1.75 mg envelope (back)
Images › 4 › U R Lhttps://www.cpsc.gov/s3fs-public/Recall.2016.16232.16232d.jpg
Images › 4 › CaptionNovel Laboratories sleep tablets 3.5 mg box (front)
Images › 5 › U R Lhttps://www.cpsc.gov/s3fs-public/Recall.2016.16232.16232e.jpg
Images › 5 › CaptionNovel Laboratories sleep tablets 3.5 mg envelope (front)
Images › 6 › U R Lhttps://www.cpsc.gov/s3fs-public/Recall.2016.16232.16232f.jpg
Images › 6 › CaptionNovel Laboratories sleep tablets 3.5 mg envelope (back)
Hazards › NameThe packaging for the prescription drug is not child-resistant as required by the Poison Prevention Packaging Act, posing a risk of poisoning if swallowed by children.
Injuries › NameNone reported
Products › NameZolpidem Tartrate Sublingual tablets
Products › TypeTablet or Capsule Drugs
Products › Category I D68198
Products › Number Of UnitsAbout 5,700 boxes of 30 blister packs
Recall I D7814
Remedies › NameConsumers should immediately stop using the recalled tablets and contact Novel Laboratories for instructions to receive a full refund.
Retailers › NameClinics and pharmacies nationwide, including CVS, Costco, Walgreens, Kroger, and Wegmans from March 2016 through May 2016 for about $800 per box of 30 tablets.
Recall Date2016-07-27T00:00:00
DescriptionThis recall involves 1.75 mg and 3.5 mg Zolpidem Tartrate sublingual (rapid dissolve) tablets from Novel Laboratories. The prescription medication is a sleep drug. The packaging for the 1.75 mg tablets has lot number M16140A, 1.75 mg and national drug code (NDC) 43386-762-30. The packaging for the 3.5 mg tablets has lot number M16144A, 3.5mg and national drug code (NDC) 43386-761-30. The Zolpidem Tartrate is packaged as a single tablet in a peel-and-push blister pack inside an outer open-ended pouch with 30 pouches per box. The lot number and an expiration date of 02/2018 are printed on the bottom left of the pouches. The NDC is printed on the top left corner of the boxes. "Gavis" is printed in blue on the center of the white boxes and pouches.
Product U P Cs › 1 › U P C343386761012
Product U P Cs › 2 › U P C343386762019
Distributors › NameGavis Pharmaceuticals, of Somerset, N.J.
Recall Number16232
Manufacturers › NameNovel Laboratories, of Somerset, N.J.
Remedy Options › OptionRefund
Consumer ContactNovel Laboratories toll-free at (866) 403-7592 from 9 a.m. to 5 p.m. ET Monday through Friday or online at www.novellabs.net and click on "Important Zolpidem Information" for more information.
Last Publish Date2016-07-27T00:00:00
Manufacturer Countries › CountryUnited States

Check Other Products In Your Household

Free Safety Tools

Safety recalls are issued daily across foods, medications, vehicles, and electronics. Use our instant tools to check your home for active safety warnings:

Overview

  • Recalling FirmNovel Laboratories, of Somerset, N.J.
Recall Hazard Severity
Caution (Class III)
Official Agency Alert

📢 Share Warning

Alert family and friends to keep them safe. Copy this quick alert message:

🚨 SAFETY ALERT: Novel Laboratories, of Somerset, N.J. - Novel Laboratories Recalls Zolpidem Tartrate Blister Packs Due to Failure to Meet Child-Resistant Closure Requirement; Risk of Poisoning

Check if your household is affected:
https://therecallfile.com/recalls/novel-laboratories-recalls-zolpidem-tartrate-blister-packs-due-to-fail/CPSC-16232
WhatsAppFacebook

Join Alertlist

Get instant email updates whenever critical safety recalls like this are published.

Featured on Product Hunt

Help support our public safety mission and check out our community launch.

The Recall File - The Google for Product Recalls | Product Hunt

Support The Recall File

Help keep official recall alerts free, accessible, and fast for everyone.

Donate with PayPal

Supports USD, EUR, GBP, International Cards & PayPal

Spread the WordNovel Laboratories Recalls Zolpidem Tartrate Blister Packs Due to Failure to Meet Child-Resistant Closure Requirement; Risk of Poisoning

Install The Recall File App

Check safety warnings, scan your pantry, and monitor your vehicles directly from your home screen.